TCL Archive Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products. October 8, 2004
TCL Archive A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI. May 19, 2006
TCL Archive FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention” November 6, 1998
TCL Archive President’s Budget Asks $1.646 Billion for NCI In FY 1990, Including AIDS, 3% Increase Over ‘89 January 13, 1989
TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
